Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France

被引：51
|
作者：
Bodilis, Helene [2 ]
Guiso, Nicole [1 ]
机构：
[1] Inst Pasteur, F-75724 Paris 15, France
[2] CNRS, F-75700 Paris, France
来源：
EMERGING INFECTIOUS DISEASES | 2013年 / 19卷 / 03期
关键词：
STRAINS; VACCINE;
D O I：
10.3201/1903.121475
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where acellular pertussis vaccines have been used for >7 years. We analyzed data from France and compared clinical symptoms among infants <6 months old infected by PRN-positive or PRN-negative isolates. No major clinical differences were found between the 2 groups.
引用
收藏
页码：471 / 474
页数：4
相关论文
共 50 条
  • [1] Pertactin-Negative Variants of Bordetella pertussis in the United States
    Queenan, Anne Marie
    Cassiday, Pamela K.
    Evangelista, Alan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (06): : 583 - 584
  • [2] Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
    Martin, Stacey W.
    Pawloski, Lucia
    Williams, Margaret
    Weening, Keeley
    DeBolt, Chas
    Qin, Xuan
    Reynolds, Laura
    Kenyon, Cynthia
    Giambrone, Gregory
    Kudish, Kathy
    Miller, Lisa
    Selvage, David
    Lee, Adria
    Skoff, Tami H.
    Kamiya, Hajime
    Cassiday, Pamela K.
    Tondella, Maria L.
    Clark, Thomas A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) : 223 - 227
  • [3] Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017
    Xu, Zheng
    Octavia, Sophie
    Luu, Laurence Don Wai
    Payne, Michael
    Timms, Verlaine
    Tay, Chin Yen
    Keil, Anthony D.
    Sintchenko, Vitali
    Guiso, Nicole
    Lan, Ruiting
    [J]. EMERGING INFECTIOUS DISEASES, 2019, 25 (06) : 1196 - 1199
  • [4] Pertactin-negative variants of Bordetella pertussis in New York State: A retrospective analysis, 2004-2013
    Quinlan, Tammy
    Musser, Kimberlee A.
    Currenti, Salvatore A.
    Zansky, Shelley M.
    Halse, Tanya A.
    [J]. MOLECULAR AND CELLULAR PROBES, 2014, 28 (04) : 138 - 140
  • [5] Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland
    Mooi, FR
    He, QS
    van Oirschot, H
    Mertsola, J
    [J]. INFECTION AND IMMUNITY, 1999, 67 (06) : 3133 - 3134
  • [6] Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines
    Hegerle, Nicolas
    Guiso, Nicole
    [J]. EXPERT REVIEW OF VACCINES, 2014, 13 (09) : 1135 - 1146
  • [7] Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom
    Fry, NK
    Neal, S
    Harrison, TG
    Miller, E
    Matthews, R
    George, RC
    [J]. INFECTION AND IMMUNITY, 2001, 69 (09) : 5520 - 5528
  • [8] Bordetella parapertussis isolates not expressing pertactin circulating in France
    Bouchez, V.
    Brun, D.
    Dore, G.
    Njamkepo, E.
    Guiso, N.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (05) : 675 - 682
  • [9] Structure of Bordetella pertussis virulence factor P.69 pertactin
    Emsley, P
    Charles, IG
    Fairweather, NF
    Isaacs, NW
    [J]. NATURE, 1996, 381 (6577) : 90 - 92
  • [10] Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin
    Hegerle, N.
    Paris, A. -S.
    Brun, D.
    Dore, G.
    Njamkepo, E.
    Guillot, S.
    Guiso, N.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (09) : E340 - E346
12345